Search Results - "Smith, U."

Refine Results
  1. 1

    Adipose tissue regulates insulin sensitivity: role of adipogenesis, de novo lipogenesis and novel lipids by Smith, U., Kahn, B. B.

    Published in Journal of internal medicine (01-11-2016)
    “…Obesity, the major cause of the current global epidemic of type 2 diabetes (T2D), induces insulin resistance in peripheral insulin target tissues. Several…”
    Get full text
    Journal Article
  2. 2

    12th Key Symposium Introduction: insulin resistance in common diseases by Smith, U.

    Published in Journal of internal medicine (01-11-2016)
    “…Content List – Read more articles from the symposium: 12th Key Symposium ‐ Insulin Resistance in Common Diseases…”
    Get full text
    Journal Article
  3. 3

    Similar response of labile and resistant soil organic matter pools to changes in temperature. [Erratum: 2005 Aug. 11, v. 436, no. 7052, p. 881.] by Fang, C, Smith, P, Moncrieff, J.B, Smith, J.U

    Published in Nature (06-01-2005)
    “…Our understanding of the relationship between the decomposition of soil organic matter (SOM) and soil temperature affects our predictions of the impact of…”
    Get full text
    Journal Article
  4. 4

    Adipose tissue distribution and risk of metabolic disease: does thiazolidinedione-induced adipose tissue redistribution provide a clue to the answer by Yang, X, Smith, U

    Published in Diabetologia (01-06-2007)
    “…The relative effect of visceral and subcutaneous obesity on the risk of chronic metabolic disease has been a matter of long-term dispute. While ample data…”
    Get full text
    Journal Article
  5. 5

    Family history of type 2 diabetes increases the risk of both obesity and its complications: is type 2 diabetes a disease of inappropriate lipid storage? by Cederberg, H., Stančáková, A., Kuusisto, J., Laakso, M., Smith, U.

    Published in Journal of internal medicine (01-05-2015)
    “…Objectives The aim of this study was to characterize diabetes risk in relation to amount and distribution of body fat (environmental factors) and genetic risk…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Pioglitazone: mechanism of action by Smith, U

    “…Thiazolidinediones, such as pioglitazone, are synthetic ligands for peroxisome proliferator-activated receptors (PPARs). They alter the transcription of genes…”
    Get more information
    Journal Article
  8. 8
  9. 9

    Impaired ('diabetic') insulin signaling and action occur in fat cells long before glucose intolerance¾is insulin resistance initiated in the adipose tissue by Smith, U

    Published in International Journal of Obesity (01-07-2002)
    “…This review postulates and presents recent evidence that insulin resistance is initiated in the adipose tissue and also suggests that the adipose tissue may…”
    Get full text
    Journal Article
  10. 10

    Recent advances in the molecular pathology, cell biology and genetics of ciliopathies by Adams, M, Smith, U M, Logan, C V, Johnson, C A

    Published in Journal of medical genetics (01-05-2008)
    “…Primary cilia have a broad tissue distribution and are present on most cell types in the human body. Until recently, they were considered to be redundant…”
    Get more information
    Journal Article
  11. 11

    AMP-activated protein kinase inhibits IL-6-stimulated inflammatory response in human liver cells by suppressing phosphorylation of signal transducer and activator of transcription 3 (STAT3) by Nerstedt, A, Johansson, A, Andersson, C. X, Cansby, E, Smith, U, Mahlapuu, M

    Published in Diabetologia (01-11-2010)
    “…Aim/hypothesis The aim of the study was to examine the possible role of AMP-activated protein kinase (AMPK) in the regulation of the inflammatory response…”
    Get full text
    Journal Article
  12. 12

    Adipocyte-released insulin-like growth factor-1 is regulated by glucose and fatty acids and controls breast cancer cell growth in vitro by D’Esposito, V., Passaretti, F., Hammarstedt, A., Liguoro, D., Terracciano, D., Molea, G., Canta, L., Miele, C., Smith, U., Beguinot, F., Formisano, P.

    Published in Diabetologia (01-10-2012)
    “…Aims/hypothesis Type 2 diabetes and obesity are associated with increased risk of site-specific cancers. We have investigated whether metabolic alterations at…”
    Get full text
    Journal Article
  13. 13

    Mannose is an insulin-regulated metabolite reflecting whole-body insulin sensitivity in man by Ferrannini, E., Bokarewa, M., Brembeck, P., Baboota, R., Hedjazifar, S., Andersson, K., Baldi, S., Campi, B., Muscelli, E., Saba, A., Sterner, I., Wasen, C., Smith, U.

    Published in Metabolism, clinical and experimental (01-01-2020)
    “…Mannose is a glucose-associated serum metabolite mainly released by the liver. Recent studies have shown several unexpected pleiotropic effects of mannose…”
    Get full text
    Journal Article
  14. 14

    Overexpression of Il6 leads to hyperinsulinaemia, liver inflammation and reduced body weight in mice by Franckhauser, S, Elias, I, Rotter Sopasakis, V, Ferré, T, Nagaev, I, Andersson, C. X, Agudo, J, Ruberte, J, Bosch, F, Smith, U

    Published in Diabetologia (01-07-2008)
    “…Aims/hypothesis IL-6 is released by the adipose tissue and increased circulating levels in obesity are associated with hyperinsulinaemia and insulin…”
    Get full text
    Journal Article
  15. 15

    Water for small‐scale biogas digesters in sub‐Saharan Africa by Bansal, Vamini, Tumwesige, Vianney, Smith, Jo U.

    Published in Global change biology. Bioenergy (01-02-2017)
    “…Biogas could provide a more sustainable energy source than wood fuels for rural households in sub‐Saharan African. However, functioning of biogas digesters can…”
    Get full text
    Journal Article
  16. 16

    Thiazolidinediones increase the wingless-type MMTV integration site family (WNT) inhibitor Dickkopf-1 in adipocytes: a link with osteogenesis by Gustafson, B, Eliasson, B, Smith, U

    Published in Diabetologia (01-03-2010)
    “…Aims/hypothesis Dickkopf-1 (DKK1) is a secreted inhibitor of canonical wingless-type MMTV integration site family (WNT) signalling; the key pathway for cell…”
    Get full text
    Journal Article
  17. 17

    Intraocular Pressure and Medication Changes Associated with Xen Gel Stent: A Systematic Review of the Literature by Panarelli, Joseph F, Vera, Vanessa, Sheybani, Arsham, Radcliffe, Nathan, Fiscella, Richard, Francis, Brian A, Smith, Oluwatosin U, Noecker, Robert J

    Published in Clinical ophthalmology (Auckland, N.Z.) (01-01-2023)
    “…The Xen gel stent (Allergan Inc, an AbbVie company; Dublin, Ireland) was conceived as an option for patients requiring modest IOP reduction but for whom…”
    Get full text
    Journal Article
  18. 18

    Lowering of postprandial lipids in individuals with type 2 diabetes treated with alogliptin and/or pioglitazone: a randomised double-blind placebo-controlled study by Eliasson, B., Möller-Goede, D., Eeg-Olofsson, K., Wilson, C., Cederholm, J., Fleck, P., Diamant, M., Taskinen, M.-R., Smith, U.

    Published in Diabetologia (01-04-2012)
    “…Aims/hypothesis Pharmacological augmentation of glucagon-like peptide 1 receptor signalling by dipeptidyl peptidase 4 (DPP-4) inhibition reduced intestinal…”
    Get full text
    Journal Article
  19. 19
  20. 20

    Cancer and diabetes: are we ready for prime time by Smith, U, Gale, E. A. M

    Published in Diabetologia (01-08-2010)
    “…Without Abstract…”
    Get full text
    Journal Article